跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG
Mylan Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 25, 2021
Approval ID
2f04ef3dcbb72b63
Company
Mylan Ireland Limited
Type
Standard
Approval Details
Approval Id
2f04ef3dcbb72b63
Drug Cima Aemps Name
LENALIDOMIDA MYLAN 5 mg CAPSULAS DURAS EFG
Register Number
1201490005
Holder Company Name
Mylan Ireland Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path
/organization/mylan-ireland-limited
Authorization Date
2021-06-25
Dosage Form
CÁPSULA DURA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Mylan Ireland Limited
Company Detail Path
/organization/mylan-ireland-limited
Company Information
Pharmaceutical Company Name
MYLAN IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Legal Department
Website
http://www.mylan.ie
Active Ingredients
LENALIDOMIDA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 25, 2021
Approval ID
2f04ef3dcbb72b63
Type
Standard
Back to CIMA-AEMPS Approvals
